Prevention is better than cure for emerging infectious diseasesHEYMANN, David; DAR, Osman.BMJ (Overseas and retired doctors ed.). 2014, Vol 348, Num 7947, pp 20-22, issn 1759-2151, 3 p.Article

Challenges of drug resistance in the developing worldLAXMINARAYAN, Ramanan; HEYMANN, David.BMJ (Overseas and retired doctors ed.). 2012, Vol 344, Num 7852, pp 25-27, issn 1759-2151, 3 p.Article

Lancet mass gatherings medicine 1: Hajj: infectious disease surveillance and controlMEMISH, Ziad A; ZUMLA, Alimuddin; MCCLOSKEY, Brian et al.Lancet (British edition). 2014, Vol 383, Num 9934, pp 2073-2082, issn 0140-6736, 10 p.Article

Eradicating polioHEYMANN, David L; AYLWARD, R. Bruce.The New England journal of medicine. 2004, Vol 351, Num 13, pp 1275-1277, issn 0028-4793, 3 p.Article

Lancet mass gatherings medicine 3: Euro 2012 European Football Championship Finals: planning for a health legacySMALLWOOD, Catherine A. H; ARBUTHNOTT, Katherine G; NITZAN, Dorit et al.Lancet (British edition). 2014, Vol 383, Num 9934, pp 2090-2097, issn 0140-6736, 8 p.Article

Sécurité sanitaire mondiale : Surveillance et intervention pour les épidémies et les maladies émergentesRODIER, Guénaël; HEYMANN, David.Annales de l'Institut Pasteur. Actualités. 2001, Num 8, pp 13-20, issn 0924-4204Article

Emerging respiratory tract infections 2: Emerging infectious diseases and pandemic potential: status quo and reducing risk of global spreadMcCLOSKEY, Brian; DAR, Osman; ZUMLA, Alimuddin et al.Lancet. Infectious diseases (print). 2014, Vol 14, Num 10, pp 1001-1010, issn 1473-3099, 10 p.Article

New strategies for the elimination of polio from IndiaGRASSLY, Nicholas C; FRASER, Christophe; WENGER, Jay et al.Science (Washington, D.C.). 2006, Vol 314, Num 5802, pp 1150-1153, issn 0036-8075, 4 p.Article

Communicable diseases in complex emergencies: impact and challengesCONNOLLY, Maire A; GAYER, Michelle; RYAN, Michael J et al.Lancet (British edition). 2004, Vol 364, Num 9449, pp 1974-1983, issn 0140-6736, 10 p.Article

Making new vaccines affordable: a comparison of financing processes used to develop and deploy new meningococcal and pneumococcal conjugate vaccinesHARGREAVES, James R; GREENWOOD, Brian; CLIFT, Charles et al.Lancet (British edition). 2011, Vol 378, Num 9806, pp 1885-1893, issn 0140-6736, 9 p.Article

Protective efficacy of a monovalent oral type 1 poliovirus vaccine : a case-control study. CommentaryFINE, Paul E. M; ULLA KOU GRIFFITHS; AYLWARD, R. Bruce et al.Lancet (British edition). 2007, Vol 369, Num 9570, issn 0140-6736, 1321-1322,1322-1323,1356-1362 [11 p.]Article

Ecology of zoonoses: natural and unnatural historiesKARESH, William B; DOBSON, Andy; MACHALABA, Catherine C et al.Lancet (British edition). 2012, Vol 380, Num 9857, pp 1936-1945, issn 0140-6736, 10 p.Article

John Snow's legacy: epidemiology without bordersFINE, Paul; VICTORA, Cesar G; ROBERTS, Ian et al.Lancet (British edition). 2013, Vol 381, Num 9874, pp 1302-1311, issn 0140-6736, 10 p.Article

Lancet mass gatherings medicine 2: London 2012 Olympic and Paralympic Games: public health surveillance and epidemiologyMCCLOSKEY, Brian; ENDERICKS, Tina; SEVERI, Ettore et al.Lancet (British edition). 2014, Vol 383, Num 9934, pp 2083-2089, issn 0140-6736, 7 p.Article